- Home
- TDS vs ACLX Comparison
TDS vs ACLX Comparison
Compare TDS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDS
- ACLX
- Stock Information
- Founded
- TDS 1968
- ACLX 2015
- Country
- TDS United States
- ACLX United States
- Employees
- TDS N/A
- ACLX N/A
- Industry
- TDS Telecommunications Equipment
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- TDS Telecommunications
- ACLX Health Care
- Exchange
- TDS Nasdaq
- ACLX Nasdaq
- Market Cap
- TDS 4.4B
- ACLX 4.4B
- IPO Year
- TDS N/A
- ACLX 2022
- Fundamental
- Price
- TDS $39.34
- ACLX $88.70
- Analyst Decision
- TDS Buy
- ACLX Strong Buy
- Analyst Count
- TDS 2
- ACLX 12
- Target Price
- TDS $52.00
- ACLX $114.75
- AVG Volume (30 Days)
- TDS 1.1M
- ACLX 511.7K
- Earning Date
- TDS 10-31-2025
- ACLX 11-06-2025
- Dividend Yield
- TDS 0.41%
- ACLX N/A
- EPS Growth
- TDS N/A
- ACLX N/A
- EPS
- TDS N/A
- ACLX N/A
- Revenue
- TDS $4,805,000,000.00
- ACLX $56,979,000.00
- Revenue This Year
- TDS N/A
- ACLX N/A
- Revenue Next Year
- TDS $0.29
- ACLX $210.71
- P/E Ratio
- TDS N/A
- ACLX N/A
- Revenue Growth
- TDS N/A
- ACLX N/A
- 52 Week Low
- TDS $22.51
- ACLX $47.86
- 52 Week High
- TDS $42.74
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- TDS 49.76
- ACLX 68.46
- Support Level
- TDS $38.59
- ACLX $83.33
- Resistance Level
- TDS $39.88
- ACLX $89.31
- Average True Range (ATR)
- TDS 0.84
- ACLX 2.66
- MACD
- TDS 0.10
- ACLX 0.42
- Stochastic Oscillator
- TDS 59.71
- ACLX 63.77
About TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.